| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 236,455 | 243,293 | 251,093 | 280,570 | | Cost of Revenue | 112,022 | 122,772 | 122,944 | 129,310 | | | Gross Profit | 124,433 | 120,521 | 128,149 | 151,260 | | | Operating Expenses | | Research Development | 15,939 | 17,184 | 17,920 | 18,274 | | Selling General and Administrative | 70,053 | 67,488 | 71,232 | 74,095 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,441 | 35,849 | 38,997 | 58,891 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 244 | 522 | 682 | 570 | | Earnings Before Interest And Taxes | 38,685 | 36,371 | 39,679 | 59,461 | | Interest Expense | 640 | 1,103 | 1,242 | 1,213 | | Income Before Tax | 38,045 | 35,268 | 38,437 | 58,248 | | Income Tax Expense | 11,974 | 11,713 | 12,738 | 18,884 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,071 | 23,555 | 25,699 | 39,364 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,071 | 23,555 | 25,699 | 39,364 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,071 | $23,555 | $25,699 | $39,364 |
|
2.27% Nasdaq 0.00%
Income Statement
